January 06, 2025 02:52 am (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
Bharatiya Janata Party releases first list of candidates for Delhi Assembly polls, fields Parvesh Sahib Singh Verma against Kejriwal | Firecracker unit explosion in Tamil Nadu's Virudhunagar kills 6 | Body of independent journalist, who went missing on Jan 1, found in a septic tank in Chhattisgarh | Delhi: 14-year-old student stabbed to death outside school after brawl with classmate | Rohit Sharma confirms he is not retiring amid speculations after skipping Sydney Test | India objects to China's 'new counties' announcement, says parts of these come under Ladakh | No cause for alarm over HMPV virus spread in China: Indian Health Agency | PM Modi gives a call for change in Delhi launching fierce attack on Arvind Kejriwal's AAP | Quran open to passage glorifying violence, bomb-making materials tracked in New Orleans attacker Shamshud-Din Jabbar's home | Jasprit Bumrah leads India in series decider after Rohit Sharma opts to rest in Sydney Test amid poor show with willow
COVID19 Vaccine

US to possibly supply COVID-19 vaccine to other countries: Prez Donald Trump

| @indiablooms | Jul 29, 2020, at 05:52 pm

Washington/UNI:  US President Donald Trump during a press briefing said the United States may provide a vaccine for the novel coronavirus to other countries when it is ready.

"When we have that vaccine it will be discharged and taken care of," Trump told reporters on Tuesday. "It will be a very rapid process all over the country and perhaps we'll be supplying a lot of the vaccine to other parts of the world like we do with ventilators and other things that we all of a sudden have become very good at making."

The Trump administration aims to have a vaccine available by the end of the year or early 2021, says a Sputnik news report.

On Monday, the National Institutes of Health (NIH) said that US scientists have begun the phase three trial of the potential vaccine developed by the biotechnology company Moderna.

The NIH plans to conduct the trial at multiple US clinical research sites with participation of approximately 30,000 adult volunteers who are not infected with the novel coronavirus.

The United States has reported more than 4.3 million cases and more than 149,000 virus-related deaths as of Tuesday afternoon, according to data compiled by the Johns Hopkins University. 

Support Our Journalism

We cannot do without you.. your contribution supports unbiased journalism

IBNS is not driven by any ism- not wokeism, not racism, not skewed secularism, not hyper right-wing or left liberal ideals, nor by any hardline religious beliefs or hyper nationalism. We want to serve you good old objective news, as they are. We do not judge or preach. We let people decide for themselves. We only try to present factual and well-sourced news.

Support objective journalism for a small contribution.